share_log

Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technolog

Benzinga ·  2021/04/29 09:35
Capricor Therapeutics shares are trading higher after the company announced it signed an exclusive, worldwide licensing agreement with Johns Hopkins University to expand its exosome platform technology portfolio.
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする